Back to search
Unresectable Colorectal Liver Metastases
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Unresectable Colorectal Liver Metastases trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Unresectable Colorectal Liver Metastases trials you may qualify forThis phase III trial compares hepatic arterial infusion (HAI) (pump chemotherapy) in addition to standard of care chemotherapy versus standard of care chemother…
To investigate the safety and effectiveness of BSJ019T in Japanese patients with primary or secondary liver who are not candidate for standard treatment.
AGX101 is an antibody-drug conjugate (ADC) therapy for tumor-forming cancers. The purpose of this study is to learn about AGX101 effects and safety at various d…
This is a single-arm, single institution pilot registry of liver transplantation in patients with unresectable colorectal liver-only metastases at Weill Cornell…
The goal of this clinical trial is to learn if ivonescimab plus chemotherapy works to treat colorectal cancer liver metastases that cannot be completely removed…
This study is an interventional open label prospective study that aims to assess both overall and disease-free survival of patients treated with LDLT, partial o…
This prospective study aims to investigate the efficacy and safety of peritumoral injection of the oncolytic virus H101 in combination with stereotactic body ra…
This is a single-arm interventional study targeting patients with initially unresectable MSS-type advanced colorectal cancer with liver and/or lung and peritone…